Your browser doesn't support javascript.
Monitoring of SARS-CoV-2 seroprevalence among primary healthcare patients in the Barcelona Metropolitan Area: the SeroCAP sentinel network protocol.
Sentís, Alexis; Torán, Pere; Esperalba, Juliana; Agustí, Cristina; Ángel, Miguel; Fernández, Munoz Gema; Dopico, Eva; Salvador-González, Betlem; González, Maria Victoria; Bordas, Anna; Antón, Andrés; Violan, Concepció; Montoro-Fernández, Marcos; Aceiton, Jordi; Egea-Cortés, Laia; Alonso, Lucía; Dacosta-Aguayo, Rosalia; Calatayud, Laura; Lejardi, Yolanda; Mendioroz, Jacobo; Basora, Josep; Reyes-Urueña, Juliana; Casabona, Jordi.
  • Sentís A; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Torán P; Instituto de Salud Carlos III, Madrid, Spain.
  • Esperalba J; Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Barcelona, Spain.
  • Agustí C; Departament de Medicina, Universitat de Girona, Girona, Spain.
  • Ángel M; Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Fernández MG; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain cagusti@iconcologia.net.
  • Dopico E; Instituto de Salud Carlos III, Madrid, Spain.
  • Salvador-González B; Gerència Territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain.
  • González MV; IDIAP Jordi Gol, Barcelona, Spain.
  • Bordas A; Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Germans Trias i Pujol, Badalona, Spain.
  • Antón A; Microbiology Department, Laboratori Clínic Territorial Metropolitana Sud, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
  • Violan C; Unitat de Suport a la Recerca Costa de Ponent, Direcció Atenció Primària Costa de Ponent, Gerència Territorial Metropolitana Sud, Institut Català de la Salut, Barcelona, Spain.
  • Montoro-Fernández M; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Aceiton J; Instituto de Salud Carlos III, Madrid, Spain.
  • Egea-Cortés L; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Alonso L; Microbiology Department, Hospital Vall d'Hebron, Barcelona, Spain.
  • Dacosta-Aguayo R; Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
  • Calatayud L; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Lejardi Y; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Mendioroz J; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Basora J; Centre of epidemiological studies on sexually transmitted infections and AIDS of Catalunya (CEEISCAT). Department of Health, Generalitat of Catalunya, Badalona, Spain.
  • Reyes-Urueña J; Unitat de Suport a la Recerca Metropolitana Nord, IDIAP Jordi Gol, Mataró, Spain.
  • Casabona J; Microbiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
BMJ Open ; 12(2): e053237, 2022 02 09.
Article in English | MEDLINE | ID: covidwho-1677392
ABSTRACT

INTRODUCTION:

SARS-CoV-2 seroprevalence studies are currently being recommended and implemented in many countries. Forming part of the COVID-19 monitoring and evaluation plan of the Catalan Government Health Department, our network aims to initiate a primary healthcare sentinel monitoring system as a surrogate of SARS-CoV-2 exposure in the Barcelona Metropolitan Area. METHODS AND

ANALYSIS:

The seroCAP is a serial cross-sectional study, which will be performed in the Barcelona Metropolitan Area to estimate antibodies against SARS-CoV-2. From February 2021 to March 2022, the detection of serum IgG antibodies against SARS-CoV-2 trimeric spike protein will be performed on a monthly basis in blood samples collected for diverse clinical purposes in three reference hospitals from the three Barcelona healthcare areas (BCN areas). The samples (n=2588/month) will be from patients attended by 30 primary healthcare teams at 30 basic healthcare areas (BHA). A lab software algorithm will systematically select the samples by age and sex. Seroprevalence will be estimated and monitored by age, sex, BCN area and BHA. Descriptive and cluster analysis of the characteristics and distribution of SARS-CoV-2 infections will be performed. Sociodemographic, socioeconomic and morbidity-associated factors will be determined using logistic regression. We will explore the association between seroprevalence, SARS-CoV-2 confirmed cases and the implemented measures using interrupted time series analysis. ETHICS AND DISSEMINATION Ethical approval was obtained from the University Institute Foundation for Primary Health Care Research Jordi Gol i Gurina ethics committee. An informed consent is not required regarding the approval of the secondary use of biological samples within the framework of the COVID-19 pandemic. A report will be generated quarterly. The final analysis, conclusions and recommendations will be shared with the stakeholders and communicated to the general public. Manuscripts resulting from the network will be submitted for publication in peer-reviewed journals.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: BMJOPEN-2021-053237

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: BMJOPEN-2021-053237